AMENDED AND RESTATED LICENSE AGREEMENT by and between ORTHOVITA, INC. and ANGIOTECH PHARMACEUTICALS (US), INC.License Agreement • March 16th, 2007 • Orthovita Inc • Surgical & medical instruments & apparatus • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (“Agreement”) is made and entered into as of this 29th day of December 2006, by and between Orthovita, Inc., a Pennsylvania corporation with principal offices at 77 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”), and Angiotech Pharmaceuticals (US), Inc., a Washington corporation with principal offices at 101 W. North Bend Way, Suite 201, PO Box 2840, North Bend, WA 98045 (“Angiotech”), and amends and restates in its entirety that certain License Agreement executed as of March 20, 2006 and effective January 1, 2006 (the “Original Agreement”) by and between Orthovita and Angiotech.
FORM OF RETENTION PLAN AGREEMENT FOR VICE PRESIDENTSRetention Plan Agreement • March 16th, 2007 • Orthovita Inc • Surgical & medical instruments & apparatus
In connection with your position as Vice President of ____________ for Orthovita, Inc. (the “Company”), the Compensation Committee to the Board of Directors of the Company has determined to provide you with a continuation of your base salary in the event your employment with the Company is terminated in connection with a “Change of Control” of the Company (as defined in the Company’s 1997 Equity Compensation Plan). Specifically, if within one year after a Change of Control of the Company, (a) the Company terminates your employment for any reason other than “Cause” (as defined in the Company’s 1997 Equity Compensation Plan), your disability or death, or (b) you voluntarily terminate employment with the Company on account of a “Constructive Termination” (as defined below), you will receive a series of payments that is equal to a continuation of your base salary, as in effect immediately prior to your termination of employment, for a minimum of six (6) months, but not to exceed twelve (12
